Quantcast

Latest Dyadic International Inc. Stories

2011-03-10 08:15:00

JUPITER, Fla., March 10, 2011 /PRNewswire/ -- Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company, today announced financial results for the year ended December 31, 2010. The financial information contained in this press release should be read in conjunction with the financial statements, footnotes and independent auditors' report which have been posted on the OTC Markets website at www.otcmarkets.com and on Dyadic's website at www.dyadic.com. (Logo:...

2011-03-07 08:15:00

JUPITER, Fla., March 7, 2011 /PRNewswire/ -- Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company, today announced that it will release financial results for the year ended December 31, 2010 on Thursday, March 10, 2011 before market open to be followed by a conference call at 11:00 a.m. Eastern Time. (Logo: http://photos.prnewswire.com/prnh/20091214/DYADICLOGO ) The conference call may be accessed by dialing 800-967-0627 (domestic) or 913-312-0953 (international)...

2011-02-22 08:15:00

JUPITER, Fla., Feb. 22, 2011 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has launched FibreZyme® G200, a next generation, high performance enzyme designed to improve paper quality and improve the economics of various pulp and paper...

2011-02-10 08:15:00

JUPITER, Fla., Feb. 10, 2011 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,883,872 entitled, Construction of Highly Efficient Cellulase Compositions for Enzymatic Hydrolysis of Cellulose, by the United...

2010-11-15 08:15:00

JUPITER, Fla., Nov. 15, 2010 /PRNewswire-FirstCall/ -- Dyadic International, Inc. ("Dyadic") (Pink Sheets: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the third quarter ended September 30, 2010. The financial information contained in this press release should be read in...

2010-11-09 08:15:00

JUPITER, Fla., Nov. 9, 2010 /PRNewswire-FirstCall/ -- Dyadic International, Inc. (Pink Sheets: DYAI), a global biotechnology company, today announced that it will release financial results for the third quarter ended September 30, 2010 on Monday, November 15, 2010 before market open to be followed by a conference call at 11:00 a.m. Eastern Time. (Logo: http://photos.prnewswire.com/prnh/20091214/DYADICLOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20091214/DYADICLOGO ) The conference...

2010-10-13 08:15:00

JUPITER, Fla., Oct. 13 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (Pink Sheets: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,794,962 by the United States Patent and Trademark Office ("USPTO"). (Logo: http://www.newscom.com/cgi-bin/prnh/20091214/DYADICLOGO...

2010-09-08 08:15:00

JUPITER, Fla., Sept. 8 /PRNewswire-FirstCall/ -- Dyadic International, Inc. ("Dyadic") (Pink Sheets: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced that its President and Chief Executive Officer, Mark Emalfarb, will present at the Rodman & Renshaw Annual Global Investment Conference at The Palace Hotel in...

2010-09-07 08:15:00

JUPITER, Fla., Sept. 7 /PRNewswire-FirstCall/ -- Dyadic International, Inc. ("Dyadic") (Pink Sheets: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced that Dyadic has received an additional $1 million to complete its previously announced private placement of convertible subordinated secured promissory notes (the...

2010-08-24 09:15:00

JUPITER, Fla., Aug. 24 /PRNewswire-FirstCall/ -- Dyadic International, Inc. ("Dyadic") (Pink Sheets: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced that it has completed a private placement of $3,000,000 in convertible subordinated secured promissory notes (the "Notes") with two investors. (Logo:...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related